AYALA PHARMACEUTICALS
Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. Ayalaโs approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations. The com... pany has two product candidates under development, AL101 and AL02, targeting the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat a variety of tumors including Adenoid Cystic Carcinoma, Triple Negative Breast Cancer, T-cell Acute Lymphoblastic Leukemia, Desmoid Tumors and Multiple Myeloma (in collaboration with Novartis).
AYALA PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.ayalapharma.com
Total Employee:
11+
Status:
Active
Contact:
+972-8-373-1541
Email Addresses:
[email protected]
Total Funding:
72 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Current Employees Featured
Founder
Stock Details
Investors List
Sio Capital Management
Sio Capital Management investment in Post-IPO Equity - Ayala Pharmaceuticals
Redmile Group
Redmile Group investment in Post-IPO Equity - Ayala Pharmaceuticals
Harel Insurance Investments and Financial Services
Harel Insurance Investments and Financial Services investment in Series B - Ayala Pharmaceuticals
aMoon Fund
aMoon Fund investment in Series B - Ayala Pharmaceuticals
Novartis
Novartis investment in Series B - Ayala Pharmaceuticals
Israel Biotech Fund
Israel Biotech Fund investment in Series B - Ayala Pharmaceuticals
SBI Japan-Israel Innovation Fund
SBI Japan-Israel Innovation Fund investment in Series B - Ayala Pharmaceuticals
Israel Biotech Fund
Israel Biotech Fund investment in Series A - Ayala Pharmaceuticals
Official Site Inspections
http://www.ayalapharma.com Semrush global rank: 1.76 M Semrush visits lastest month: 13.29 K
- Host name: 104.21.79.254
- IP address: 104.21.79.254
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago